Market cap
$95 Mln
Revenue (TTM)
$28 Mln
P/E Ratio
--
P/B Ratio
0.3
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.3 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-7.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
979,950,016
10 Years Aggregate
CFO
$-96.69 Mln
EBITDA
$-125.74 Mln
Net Profit
$-137.49 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Zomedica (ZOM)
| -54.2 | 4.0 | -55.1 | -62.1 | -39.1 | -21.7 | -- |
|
BSE Sensex*
| -11.2 | -4.2 | -10.2 | -8.7 | 7.0 | 8.4 | 11.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
Zomedica (ZOM)
| 22.7 | -46.9 | 32.9 | -30.2 | -73.1 | -37.6 | 91.7 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Zomedica (ZOM)
|
0.1 | 95.4 | 27.5 | -101.6 | -167.9 | -60.6 | -- | 0.3 |
| 4.2 | 1,249.0 | 79.2 | -144.0 | -259.5 | -15.1 | -- | 1.7 | |
| 15.6 | 2,005.5 | 298.3 | 298.2 | 47.7 | 63.9 | 7.2 | 3.5 | |
| 5.7 | 326.5 | 0.0 | -35.1 | 131,201.1 | -71 | -- | 7.2 | |
| 9.0 | 154.9 | 0.1 | -10.4 | -20,626.3 | -84.1 | -- | 31.1 | |
| 0.2 | 9.5 | 0.1 | -25.3 | -20,363.0 | -22.2 | -- | 0.1 | |
| 9.6 | 331.4 | 51.0 | -8.4 | -13.7 | -- | -- | 9.0 | |
| 0.7 | 2.1 | 663.9 | -9.9 | -1.5 | -86 | -- | 0.2 | |
| 1.5 | 180.1 | 1.8 | -68.4 | -3,544.8 | -241.8 | -- | 5.5 | |
| 53.7 | 5,257.6 | 0.0 | -383.2 | -- | -40.4 | -- | 4.1 |
Shareholding Pattern
View DetailsAbout Zomedica (ZOM)
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic... platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan. Read more
-
President, CEO & Director
Mr. Larry C. Heaton II
-
President, CEO & Director
Mr. Larry C. Heaton II
-
Headquarters
Ann Arbor, MI
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Zomedica (ZOM)
What is the current share price of Zomedica Corp (ZOM) Today?
The share price of Zomedica Corp (ZOM) is $0.06 (NYSE) as of 06-May-2025 09:30 EDT. Zomedica Corp (ZOM) has given a return of -39.06% in the last 3 years.
What is the current PB & PE ratio of Zomedica Corp (ZOM)?
Since, TTM earnings of Zomedica Corp (ZOM) is negative, P/E ratio is not available.
The P/B ratio of Zomedica Corp (ZOM) is 0.26 times as on 06-May-2025, a 95 discount to its peers’ median range of 4.78 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
What is the 52 Week High and Low of Zomedica Corp (ZOM)?
The 52-week high and low of Zomedica Corp (ZOM) are Rs -- and Rs -- as of 19-May-2026.
What is the market cap of Zomedica Corp (ZOM)?
Zomedica Corp (ZOM) has a market capitalisation of $ 95 Mln as on 06-May-2025. As per SEBI classification, it is a Small Cap company.
Should I invest in Zomedica Corp (ZOM)?
Before investing in Zomedica Corp (ZOM), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.